{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:40:22Z","timestamp":1777606822972,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.nmni.2020.100817","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T06:58:40Z","timestamp":1605769120000},"page":"100817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt"],"prefix":"10.1016","volume":"38","author":[{"given":"M.A.M.","family":"Iesa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.M.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.I.A.","family":"Dirar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Abuzeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Borad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.","family":"Babiker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.H.E.","family":"Konozy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmni.2020.100817_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A\u00a0novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.nmni.2020.100817_bib2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMe2002387","article-title":"Covid-19\u2014navigating the uncharted","volume":"382","author":"Fauci","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.nmni.2020.100817_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.nmni.2020.100817_bib4","series-title":"World malaria report 2019","year":"2019"},{"key":"10.1016\/j.nmni.2020.100817_bib7","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/blood-2007-03-077602","article-title":"The ABO blood group system and Plasmodium falciparum malaria","volume":"110","author":"Cserti","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.nmni.2020.100817_bib8","doi-asserted-by":"crossref","first-page":"17471","DOI":"10.1073\/pnas.0705390104","article-title":"Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting","volume":"104","author":"Rowe","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmni.2020.100817_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100763","article-title":"Individuals with \u2018A\u2019 Rh-positive but not Rh-negative blood group are more vulnerable to SARS-CoV-2 infection: demographics and trend study on COVID-19 cases in Sudan","author":"Taha","year":"2020","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.nmni.2020.100817_bib10","series-title":"Relationship between the ABO blood group and the COVID-19 susceptibility. medRxiv","author":"Zhao","year":"2020"},{"key":"10.1016\/j.nmni.2020.100817_bib11","doi-asserted-by":"crossref","first-page":"109756","DOI":"10.1016\/j.mehy.2020.109756","article-title":"Is coronavirus disease 2019 (COVID-19) seen less in countries more exposed to malaria?","volume":"140","author":"Sargin","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.nmni.2020.100817_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101693","article-title":"Incidence of coronavirus disease (COVID-19) and countries affected by malarial infections","author":"Ahmed","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.nmni.2020.100817_bib13","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/S2214-109X(20)30123-6","article-title":"COVID-19 pandemic in west Africa","volume":"8","author":"Martinez-Alvarez","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.nmni.2020.100817_bib14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1126\/science.abd3902","article-title":"COVID-19 in Africa: dampening the storm?","volume":"369","author":"Mbow","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.nmni.2020.100817_bib15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4269\/ajtmh.20-0474","article-title":"Why is there low morbidity and mortality of COVID-19 in Africa?","volume":"103","author":"Njenga","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.nmni.2020.100817_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239385","article-title":"Multiple drivers of the COVID-19 spread: the roles of climate, international mobility, and region-specific conditions","volume":"15","author":"Kubota","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.nmni.2020.100817_bib17","doi-asserted-by":"crossref","first-page":"100760","DOI":"10.1016\/j.nmni.2020.100760","article-title":"What could explain the late emergence of COVID-19 in Africa?","volume":"38","author":"Lalaoui","year":"2020","journal-title":"New Microbe. New Infect"},{"key":"10.1016\/j.nmni.2020.100817_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.nmni.2020.100817_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","article-title":"A\u00a0systematic review of SARS-CoV-2 vaccine candidates","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nmni.2020.100817_bib20","series-title":"Coronavirus disease (COVID-19) situation report 72","year":"2020"},{"key":"10.1016\/j.nmni.2020.100817_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A\u00a0sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.nmni.2020.100817_bib22","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope Database (IEDB) 3.0","volume":"43","author":"Vita","year":"2015","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/j.nmni.2020.100817_bib23","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope Database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/j.nmni.2020.100817_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1874226201808010016","article-title":"Inter-pathogen peptide sharing and original antigenic sin: solving a paradox","volume":"8","author":"Kanduc","year":"2018","journal-title":"Open Immunol J"},{"key":"10.1016\/j.nmni.2020.100817_bib25","doi-asserted-by":"crossref","first-page":"W525","DOI":"10.1093\/nar\/gks438","article-title":"Immune epitope Database analysis Resource","volume":"40","author":"Kim","year":"2012","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/j.nmni.2020.100817_bib26","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkn254","article-title":"Immune epitope Database analysis Resource (IEDB-AR)","volume":"36","author":"Zhang","year":"2008","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/j.nmni.2020.100817_bib27","series-title":"Coronavirus disease (COVID-19) situation report 149","year":"2020"},{"key":"10.1016\/j.nmni.2020.100817_bib28","series-title":"Lack of COVID-19 testing undermines Africa\u2019s \u2018sucess\u2019","author":"Soy","year":"2020"},{"key":"10.1016\/j.nmni.2020.100817_bib29","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0140-6736(20)30526-2","article-title":"COVID-19: the gendered impacts of the outbreak","volume":"395","author":"Wenham","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.nmni.2020.100817_bib30","series-title":"Analysis: Africa\u2019s unexpected COVID-19 figures","author":"McCaffrey","year":"2020"},{"key":"10.1016\/j.nmni.2020.100817_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tmaid.2007.07.002","article-title":"Understanding the role of inflammatory cytokines in malaria and related diseases","volume":"6","author":"Clark","year":"2008","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.nmni.2020.100817_bib32","first-page":"1525","article-title":"The unspecific side of acquired immunity against infectious disease: causes and consequences","volume":"6","author":"Muraille","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.nmni.2020.100817_bib33","series-title":"Immunology and evolution of infectious disease","author":"Frank","year":"2002"},{"key":"10.1016\/j.nmni.2020.100817_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2017.04.008","article-title":"Original antigenic sin: a comprehensive review","volume":"83","author":"Vatti","year":"2017","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.nmni.2020.100817_bib35","doi-asserted-by":"crossref","first-page":"11080","DOI":"10.1128\/JVI.01590-14","article-title":"Impact of sequence variation in a dominant HLA-A\u221702-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells","volume":"88","author":"Ziegler","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.nmni.2020.100817_bib36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/1074-7613(95)90010-1","article-title":"Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands","volume":"2","author":"Evavold","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.nmni.2020.100817_bib37","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.4049\/jimmunol.0901607","article-title":"Quantitating T cell cross-reactivity for unrelated peptide antigens","volume":"183","author":"Ishizuka","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.nmni.2020.100817_bib38","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.immuni.2009.12.002","article-title":"The multiple mechanisms of T cell receptor cross-reactivity","volume":"31","author":"Yin","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.nmni.2020.100817_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fimmu.2019.00397","article-title":"Comprehensive review of human Plasmodium falciparum\u2013specific CD8+ T cell epitopes","volume":"10","author":"Heide","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.nmni.2020.100817_bib40","doi-asserted-by":"crossref","first-page":"110036","DOI":"10.1016\/j.mehy.2020.110036","article-title":"Coronavirus disease 2019 (COVID 19) and malaria: have anti glycoprotein antibodies a role?","volume":"143","author":"Parodi","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.nmni.2020.100817_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa455","article-title":"Plasmodium falciparum infection may protect a population from severe acute respiratory syndrome coronavirus 2 infection","author":"Panda","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.nmni.2020.100817_bib42","series-title":"SARS-CoV-2 invades host cells via a novel route: CD147-spike protein","author":"Wang","year":"2020"},{"key":"10.1016\/j.nmni.2020.100817_bib43","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12015-020-09976-7","article-title":"CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement","volume":"16","author":"Ulrich","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.nmni.2020.100817_bib44","series-title":"COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism","author":"Liu","year":"2020"},{"key":"10.1016\/j.nmni.2020.100817_bib45","doi-asserted-by":"crossref","first-page":"m2058","DOI":"10.1136\/bmj.m2058","article-title":"COVID-19 and thrombosis: what do we know about the risks and treatment?","volume":"369","author":"Wise","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.nmni.2020.100817_bib46","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.nmni.2020.100817_bib47","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"d-Dimer levels on admission to predict in-hospital mortality in patients with COVID-19","volume":"18","author":"Zhang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.nmni.2020.100817_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12288-011-0106-y","article-title":"Persistently elevated laboratory markers of thrombosis and fibrinolysis after clinical recovery in malaria points to residual and smouldering cellular damage","volume":"28","author":"Dasgupta","year":"2012","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.nmni.2020.100817_bib49","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4081\/cp.2020.1271","article-title":"COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review","volume":"10","author":"Cavezzi","year":"2020","journal-title":"Clin Pract"},{"key":"10.1016\/j.nmni.2020.100817_bib50","series-title":"Social science research network (SSRN)","article-title":"Metadichol\u00ae, a novel nano lipid formulation that inhibits SARS-CoV-2 and a multitude of pathological viruses in\u00a0vitro","author":"Raghavan","year":"2020"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297520301694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297520301694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:01:38Z","timestamp":1761854498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297520301694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":48,"alternative-id":["S2052297520301694"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2020.100817","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2020.100817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100817"}}